News &amp; Updates

Several social determinants of health (SDoH) appear to influence paediatric central nervous system (CNS) tumour outcomes, suggests a study.

Social determinants of health tied to CNS tumour outcomes

ARTISTRY-1 supports switch from complex HIV regimen to a novel single pill

04 Mar 2026 by

The phase II/III open-label ARTISTRY-1 trial shows that people living with HIV (PWH) may simplify their complex regimen (CR) by switching to a novel daily single-tablet regimen (STR) comprising bictegravir and lenacapavir (BIC+LEN).

ARTISTRY-1 supports switch from complex HIV regimen to a novel single pill

04 Mar 2026

Atropine eye drops reduce gamma zone enlargement over 3 years

04 Mar 2026 by

Low-concentration atropine reduced parapapillary gamma zone enlargement in a concentration-dependent manner over 3 years. Continuous treatment with 0.05 percent atropine demonstrated efficacy in controlling gamma zone development, according to latest findings from the LAMP Gamma zone study presented by study author Dr Jason Yam of the Chinese University of Hong Kong at APAO 2026.

Atropine eye drops reduce gamma zone enlargement over 3 years

Asthma severity in teens increases in presence of anxiety

Anxiety appears to influence asthma severity in adolescents, as shown in a recent cross-sectional study.

Asthma severity in teens increases in presence of anxiety

Dissolvable biosensor can help track medication adherence

US-based scientists have developed a bioresorbable, passive Radio Frequency Identification (RFID) system that enables precise monitoring of medication ingestion events in a bid to improve therapeutic outcomes and reduce healthcare expenditures.

Dissolvable biosensor can help track medication adherence

Is pembrolizumab plus RT safe to administer in TNBC?

Combination treatment with pembrolizumab and adjuvant radiotherapy (RT) does not pose any serious risk to patients with triple-negative breast cancer (TNBC), showing no increase in radiation-related adverse events (AEs), a study has shown.

Is pembrolizumab plus RT safe to administer in TNBC?

Sacituzumab tirumotecan feasible in advanced urothelial carcinoma

Treatment with sacituzumab tirumotecan (sac-TMT) shows a promising antitumour activity and an acceptable safety profile in patients with heavily pretreated advanced or metastatic urothelial carcinoma (UC), according to a phase II study.

Sacituzumab tirumotecan feasible in advanced urothelial carcinoma

Tucatinib-T-DM1 combo improves PFS in patients with metastatic breast cancer

Treatment with trastuzumab emtansine (T-DM1) plus tucatinib safely prolongs progression-free survival (PFS) in patients with previously treated HER2-positive locally advanced (LA) or metastatic breast cancer (MBC), including those with brain metastases, reports a study.

Tucatinib-T-DM1 combo improves PFS in patients with metastatic breast cancer

03 Mar 2026

TENS effectively delivers post-CS pain relief

A prospective quasi-randomized controlled trial presented at SMFM 2026 has demonstrated the potential of transcutaneous electrical nerve stimulation (TENS) to reduce postoperative pain following Caesarean delivery.

TENS effectively delivers post-CS pain relief

Nirsevimab protects against LRTI-related hospitalizations, ED visits in young children

Treatment with nirsevimab helps reduce hospitalizations and emergency department (ED) visits associated with lower respiratory tract infections (LRTIs) in infants and young children, according to the results of a meta-analysis.

Nirsevimab protects against LRTI-related hospitalizations, ED visits in young children